These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2296619)

  • 61. The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?
    Srinivasan J; Schmidt WJ
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):629-38. PubMed ID: 15118809
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sensory modulation of juvenile play in rats.
    Siviy SM; Panksepp J
    Dev Psychobiol; 1987 Jan; 20(1):39-55. PubMed ID: 3556783
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synaptosomal free [Ca2+] is reduced by clonidine and dynorphin A-(1-13) and increased by idazoxan.
    Adamson P; McWilliam JR; Brammer MJ; Campbell IC
    Eur J Pharmacol; 1987 Oct; 142(2):261-6. PubMed ID: 2891545
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An alpha 2 antagonist, idazoxan, enhances EPSP-spike coupling in the rat dentate gyrus.
    Richter-Levin G; Segal M; Sara S
    Brain Res; 1991 Feb; 540(1-2):291-4. PubMed ID: 1675916
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Extracellular brain cortical levels of noradrenaline in ischemia: effects of desipramine and postischemic administration of idazoxan.
    Gustafson I; Westerberg EJ; Wieloch T
    Exp Brain Res; 1991; 86(3):555-61. PubMed ID: 1684752
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antagonistic effect of idazoxan on xylazine-induced central nervous system depression and bradycardia in calves.
    Thompson JR; Hsu WH; Kersting KW
    Am J Vet Res; 1989 May; 50(5):734-6. PubMed ID: 2729718
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protection against ischemia-induced neuronal damage by the alpha 2-adrenoceptor antagonist idazoxan: influence of time of administration and possible mechanisms of action.
    Gustafson I; Westerberg E; Wieloch T
    J Cereb Blood Flow Metab; 1990 Nov; 10(6):885-94. PubMed ID: 1976642
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of idazoxan on evening melatonin plasma concentrations in healthy volunteers.
    Grasby PM; Begg EJ; Gartside SE; Cowen PJ
    Biol Psychiatry; 1989 Aug; 26(4):412-6. PubMed ID: 2569897
    [No Abstract]   [Full Text] [Related]  

  • 69. Effects of the alpha 2-adrenergic agonist clonidine and its antagonist idazoxan on the fetal lamb.
    Bamford OS; Dawes GS; Denny R; Ward RA
    J Physiol; 1986 Dec; 381():29-37. PubMed ID: 2887648
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discrimination between alpha 2-adrenoceptors and [3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells.
    Langin D; Paris H; Dauzats M; Lafontan M
    Eur J Pharmacol; 1990 Apr; 188(4-5):261-72. PubMed ID: 1973120
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dorsomedial diencephalic involvement in the juvenile play of rats.
    Siviy SM; Panksepp J
    Behav Neurosci; 1985 Dec; 99(6):1103-13. PubMed ID: 3038140
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of xylazine hydrochloride as the sole immobilizing agent in moose and caribou--and its subsequent reversal with idazoxan.
    Doherty TJ; Tweedie DP
    J Wildl Dis; 1989 Jan; 25(1):95-8. PubMed ID: 2563404
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influence of idazoxan on the respiratory blood gas changes induced by alpha 2-adrenoceptor agonist drugs in conscious sheep.
    Waterman AE; Nolan A; Livingston A
    Vet Rec; 1987 Aug; 121(5):105-7. PubMed ID: 2889284
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alpha-adrenoreceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on alpha-adrenoreceptor activity.
    Chapleo CB; Myers PL; Butler RC; Davis JA; Doxey JC; Higgins SD; Myers M; Roach AG; Smith CF; Stillings MR
    J Med Chem; 1984 May; 27(5):570-6. PubMed ID: 6143826
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adrenergic and opioidergic modulation of a spinal reflex in the decerebrated rabbit.
    Clarke RW; Ford TW; Taylor JS
    J Physiol; 1988 Oct; 404():407-17. PubMed ID: 2908126
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Autoregulation and monoamine interactions in the ventral tegmental area in the absence and presence of cocaine: a microdialysis study in freely moving rats.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1597-610. PubMed ID: 7996474
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Different sites of action for alpha 2-adrenoceptor antagonists in the modulation of noradrenaline release and contraction response in the vas deferens of the rat.
    Harsing LG; Vizi ES
    J Pharm Pharmacol; 1992 Mar; 44(3):231-4. PubMed ID: 1354730
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of alpha-2-adrenoceptors in the control of ACTH secretion; interaction with the opioid system.
    al-Damluji S; Bouloux P; White A; Besser M
    Neuroendocrinology; 1990 Jan; 51(1):76-81. PubMed ID: 1968233
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes.
    Ostenson CG; Pigon J; Doxey JC; Efendic S
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1054-9. PubMed ID: 2903169
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enhanced noradrenergic neuronal activity increases homovanillic acid levels in cerebrospinal fluid.
    Scheinin H
    J Neurochem; 1986 Sep; 47(3):665-7. PubMed ID: 3016178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.